Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02347995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Resistive Training Combined With Nutritional Therapy After Stroke

Study acronym: REPS
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Eligibility criteria expanded, about 15 words · Secondary endpoints: details revised at 1 of 3 entries · Publications: details revised at 1 of 1 entry · 1 more Show 4 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 1 word
  2. Primary completion date: Dec 31, 2025 to Aug 31, 2026 Completion date: Dec 31, 2026 to Aug 31, 2026v23 Show 1 more changeShow less
    • Completion date: Dec 31, 2026 to Aug 31, 2026
  3. Primary completion date: Dec 31, 2024 to Dec 31, 2025 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 150 to confirmed 93 · Completion date: Dec 31, 2025 to Dec 31, 2026 · 1 morev22 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 93
    • Completion date: Dec 31, 2025 to Dec 31, 2026
    • Site details revised
  4. Primary completion date: Jul 1, 2024 to Dec 31, 2024 Completion date: Oct 1, 2024 to Dec 31, 2025v21 Show 1 more changeShow less
    • Completion date: Oct 1, 2024 to Dec 31, 2025
  5. Primary completion date: Jul 1, 2023 to Jul 1, 2024 Completion date: Oct 1, 2023 to Oct 1, 2024v20 Show 1 more changeShow less
    • Completion date: Oct 1, 2023 to Oct 1, 2024
Show 18 earlier versionsHide 18 earlier versions
  1. Re-verified, no change to tracked fieldsv19
  2. Primary completion date: Jul 1, 2022 to Jul 1, 2023 Completion date: Oct 1, 2022 to Oct 1, 2023v18 Show 1 more changeShow less
    • Completion date: Oct 1, 2022 to Oct 1, 2023
  3. Primary completion date: Jul 1, 2021 to Jul 1, 2022 Completion date: Oct 1, 2021 to Oct 1, 2022v17 Show 1 more changeShow less
    • Completion date: Oct 1, 2021 to Oct 1, 2022
  4. Primary completion date: Apr 1, 2021 to Jul 1, 2021v16
  5. Primary completion date: Aug 21, 2020 to Apr 1, 2021 Completion date: Jan 30, 2021 to Oct 1, 2021v15 Show 1 more changeShow less
    • Completion date: Jan 30, 2021 to Oct 1, 2021
  6. Completion date: Oct 1, 2020 to Jan 30, 2021v14
  7. Primary completion date: Jun 1, 2020 to Aug 21, 2020 Completion date: Jun 1, 2020 to Oct 1, 2020 · Site contact updatedv13 Show 2 more changesShow less
    • Completion date: Jun 1, 2020 to Oct 1, 2020
    • Site contact updated
  8. Re-verified, no change to tracked fieldsv12
  9. Eligibility criteria shortened, about 14 wordsv11 See this version in full on ClinicalTrials.gov ↗
  10. Site contact updatedv10
  11. Secondary endpoints revised (3)v9 See this version in full on ClinicalTrials.gov ↗
  12. Re-verified, no change to tracked fieldsv8
  13. Primary and study completion dates: Jun 2019 to Jun 1, 2020 Start date: Aug 2015 to Aug 24, 2015 · Secondary endpoints: details revised at 1 of 3 entriesv7 Show 2 more changesShow less
    • Start date: Aug 2015 to Aug 24, 2015
    • Secondary endpoints: details revised at 1 of 3 entries
  14. Eligibility criteria shortened, about 5 wordsv6 See this version in full on ClinicalTrials.gov ↗
  15. Eligibility criteria shortened, about 2 wordsv5 See this version in full on ClinicalTrials.gov ↗
  16. Lead sponsor: US Department of Veterans Affairs to VA Office of Research and Development Study description revisedv4 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  17. Trial status: Not Yet Recruiting to Recruiting Start date: Jun 2015 to Aug 2015 · Study sites: 2 to 1 · Study description shortened, about 4 wordsv3 Show 3 more changesShow less
    • Start date: Jun 2015 to Aug 2015
    • Study sites: 2 to 1
    • Study description shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  18. Lead sponsor: Baltimore VA Medical Center to US Department of Veterans Affairs Secondary endpoints revised (3) · Study sites revised (2) · Collaborators expanded, about 4 wordsv2 Show 3 more changesShow less
    • Secondary endpoints revised (3)
    • Study sites revised (2)
    • Collaborators expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stroke survivors experience severe muscle wasting during the chronic phase of recovery, with implications for strength, function and general health. Although resistive exercise training effectively combats this problem, it is unknown whether sub-optimal protein intake limits the observed gains in skeletal muscle growth. Skeletal muscle adaptations may occur when resistive training (RT) is combined with nutritional therapy in the form of post- exercise protein consumption. This study would be the first to directly compare RT+protein supplementation to RT+placebo (same calories as protein supplement) in those with chronic hemiparesis caused by stroke, providing evidence-based rationale for combination therapy in the clinical care of this population.
Trial Details
NCT Number NCT02347995
Lead Sponsor VA Office of Research and Development
Collaborators: Baltimore VA Medical Center
Conditions Stroke
Enrollment 93 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov